Themes / Group
Active · established relationshipLatest completed snapshot · Aug 5 · 18:02 ET

MARKET-DISCOVERED GROUP

Healthcare Investment Firms

THE TRADER READShared activity without a clean directional read

Price direction is split across 12 measured members. Capital-flow agreement is 11%, so the basket is not yet clean.

Price breadth3 up · 9 downRelative median unavailable
Capital-flow alignment11%Price breadth is not yet confirmed by flow
Activity nowHotActivity score 86/100 · lift 1.3×
Evidence depth2 episodesLow sample—context, not a validated playbook
EVIDENCE CLOCK

What happened, in timestamp order

0 timed events
TIMING READA causal timing read is unavailable because no material member price onset could be timestamped.

No session event has enough timestamp precision to place on the clock.

2 earlier filing context receipts

WED, OCT 29DXCM filing documented shared operating contextproduct pipeline / R&D affecting expense · date precision only

TUE, NOV 4EW filing documented shared operating contextproduct pipeline / R&D affecting expense · date precision only

Headline times and retained activity confirmations are point-in-time evidence. Price order is inferred from aligned 5-minute bars. Filing evidence has date precision only and is context, not an intraday catalyst claim.

01 · WHAT IS HAPPENING

The move, the flow and who is driving it

Price breadth, unusual activity and signed capital flow are separate observations
Price sequence unavailableA timestamped price sequence is unavailable.
RELATIVE CO-MOVEMENT

How the members are behaving together

Session-normalized

Observed intraday paths are not available for this group yet.

02 · WHY IT MATTERS

Why now and where the move could travel

Context and lead/lag links are evidence, not proof of causation or a forecast
WHY NOW

Verified recent context

0 items

No verified recent catalyst is attached to this move. The relationship may be market-led rather than news-led.

WHY THIS GROUP EXISTS

Shared filing context

10/12 members covered

Moderate filing support: the strongest shared 10-Q/K outlook is operating setup (near-term outlook) across DG, DXCM, EW, IDXX, ISRG, LFST, LYV, ULS.

product pipeline / R&D affecting expense

“34 Table of Contents Nine Months Ended September 30, 2025 Compared to Nine Months Ended September 30, 2024 Research and development expense Research and development expense increased primarily due to $37.1 million in higher compensation and related costs, offset by $4.8 million in lower clinical trials, supplies, and other support costs.”

DXCM 10-Q · 2025-10-30
demand / volume affecting revenue

“The increase in CAG Diagnostics recurring revenue was primarily due to higher volumes in IDEXX VetLab consumables and reference laboratory testing partially offset by macroeconomic and sector headwinds, as well as benefits from higher realized prices.”

IDXX 10-Q · 2025-11-03
credit / rates

“Cash Flows from Financing Activities The increase in net cash used in financing activities, as compared to the prior period, was primarily due to: • higher share repurchases of $105 million and • a reduction in net borrowings on long-term debt of $77 million, primarily related to borrowings under the Term Loan A due 2030 in the current year as compared to the issuance of the First Lien Term Loan B-2 due 2032 in the prior year, partially offset by the partial redemptions of the First Lien Notes due 2026, and • an increase in net repayments on our 2020 Receivables Facility of $59 million.”

ADT 10-Q · 2026-07-30
CONFIRMATION NETWORK

Outsiders and cross-asset links

0 outsiders confirming

No qualified cross-asset lead/lag link is available for this group.

Filing-linked outsiders test whether the move is spreading beyond the established cohort.

AORTNot confirming

EW · text peer

MMSINot confirming

EW · text peer

PENNot confirming

ISRG · text peer

PMIRelationship only · live confirmation unavailable

ISRG · text peer

03 · WHO IS IN IT

Member participation

Unusual activity and daily price direction are shown separately
MANUHCMLLYVADGLYVULSIDXXEWADTLFSTDXCMISRG

12/12 active3 rising · 9 falling

MemberUnusual activityToday's moveRead now
MANUManchester
Most unusual · 100/100
+0.4%
Active; unclassifiedActive in 7.7% of observed group sessions
HCMHUTCHMED (China) Limited
Elevated · 90/100
+0.5%
Active; unclassifiedActive in 7.7% of observed group sessions
LLYVALiberty Live Holdings, Inc.
Elevated · 67/100
-0.4%
Active; unclassifiedActive in 7.7% of observed group sessions
DGDollar General Corporation
Elevated · 53/100
-1.4%
Active; unclassifiedActive in 15.4% of observed group sessions
LYVLive Nation Entertainment, Inc.
Elevated · 47/100
-1.3%
Flow confirmerActive in 7.7% of observed group sessions
ULSUL Solutions Inc.
Elevated · 46/100
-1.1%
Active; unclassifiedActive in 0% of observed group sessions
IDXXIDEXX Laboratories, Inc.
Elevated · 43/100
-2.9%
Flow confirmerActive in 15.4% of observed group sessions
EWEdwards Lifesciences Corporation
Elevated · 41/100
-2.7%
Flow divergenceActive in 23.1% of observed group sessions
ADTADT Inc.
Elevated · 37/100
-0.4%
Active; unclassifiedActive in 15.4% of observed group sessions
LFSTLifeStance Health Group, Inc.
Elevated · 35/100
-1.4%
Active; unclassifiedActive in 23.1% of observed group sessions
DXCMDexCom, Inc.
Elevated · 29/100
+0.4%
Flow confirmerActive in 38.5% of observed group sessions
ISRGIntuitive Surgical, Inc.
Elevated · 27/100
-5.9%
Flow confirmerActive in 30.8% of observed group sessions
View exact member values
TICKERCompanyRole nowTodayObserved historyTrader interpretation
MANUManchesterMost unusual+0.4%7.7% of 13 sessionsMost unusual activity in this snapshot; performance direction may differ.
HCMHUTCHMED (China) LimitedParticipating+0.5%7.7% of 13 sessionsPrice participation is not yet confirmed by per-name flow.
LLYVALiberty Live Holdings, Inc.Participating-0.4%7.7% of 13 sessionsPrice participation is not yet confirmed by per-name flow.
DGDollar General CorporationParticipating-1.4%15.4% of 13 sessionsPrice participation is not yet confirmed by per-name flow.
LYVLive Nation Entertainment, Inc.Participating-1.3%7.7% of 13 sessionsPrice participation with accumulating signed flow.
ULSUL Solutions Inc.Participating-1.1%0% of 13 sessionsPrice participation is not yet confirmed by per-name flow.
IDXXIDEXX Laboratories, Inc.Participating-2.9%15.4% of 13 sessionsPrice participation with accumulating signed flow.
EWEdwards Lifesciences CorporationParticipating-2.7%23.1% of 13 sessionsPrice participation with distributing signed flow.
ADTADT Inc.Participating-0.4%15.4% of 13 sessionsPrice participation is not yet confirmed by per-name flow.
LFSTLifeStance Health Group, Inc.Participating-1.4%23.1% of 13 sessionsPrice participation is not yet confirmed by per-name flow.
DXCMDexCom, Inc.Participating+0.4%38.5% of 13 sessionsPrice participation with accumulating signed flow.
ISRGIntuitive Surgical, Inc.Participating-5.9%30.8% of 13 sessionsPrice participation with accumulating signed flow.

04 · HAS THIS HAPPENED BEFORE

Identity history versus measured outcomes

Structural recurrence is not the same as a validated trading outcome
POINT-IN-TIME LIVE OUTCOMES

Live outcome ledger collecting

0/0 events completed

No completed point-in-time outcome is available yet. New live confirmations are now retained with their exact observation timestamp; statistics appear only after the corresponding candles complete.

Only point-in-time live watcher observations and conservative same-day EOD observations are included. Later backfills and replay runs are excluded.
Low structural sample

Only 2 completed episodes across 13 active sessions; treat history as context, not a validated playbook. These episode counts describe recurrence; the outcome ledger above is the only forward-performance evidence.

Structural support20 daysHow often the cohort identity was observed
Completed episodes2Separate periods of broad group activity
Active sessions13Completed session observations, not trades
2026-07-14 → 2026-08-0310 active sessionsNo name was active through every recorded session
2026-07-07 → 2026-07-093 active sessions14.3% composition consistency through the episode
MEMBER CONSISTENCY IN OBSERVED ACTIVE SESSIONS
DXCM38.5% · 2 episodes
ISRG30.8% · 2 episodes
EW23.1% · 1 episode
LFST23.1% · 2 episodes
ADT15.4% · 1 episode
DG15.4% · 1 episode
IDXX15.4% · 2 episodes
HCM7.7% · 1 episode
LLYVA7.7% · 1 episode
LYV7.7% · 1 episode
MANU7.7% · 1 episode
ULS0% · 0 episodes